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Evidence of hyperinsulinaemia and
hypoxaemia in the cord blood of neonates
born to mothers with gestational diabetes
C.M.MACFARLANE, N.TSAKALAKOS
Summary
Increased cord blood C-peptide levels in neonates
born to mothers with gestational diabetes (GO) were
directly correlated with the increased relative birth
weight ratio (BWR) of these neonates. In addition, the
percentage oxygen saturation of the cord blood was
inversely correlated with cord blood C-peptide levels
and with the relative BWR. These correlations were
absent in neonates delivered to normal mothers. The
results indicate the presence of both hyper-
insulinaemia and mild hypoxaemia in neonates of
mothers with GO. In poorly controlled diabetic
pregnancy this hypoxaemia may constitute an im-
portant fetal risk factor.
S AI, Med J 1985; 67: 81-84.
Macrosomia in infants born to diabetic mothers is most com-
monly attributed to poor blood glucose control in the
mother l -) and the development of hyperinsulinaemia in the
fetus. 4 .5 In addition, it has been shown that poor control of
diabetes in adults gives rise to increased levels of glycosylated
haemoglobin.6-8 It has been suggested that this increase in
abnormal haemoglobin may affect maternal9,1O and placental' I
oxygen transport, and that this may constitute an additional
fetal risk factor during diabetic pregnancy. In pregnant insulin-
dependent diabetic patients, Widness el al. 12 found no corre-
lation between HbA Ic and maternal P50 (partial pressure of
oxygen at which haemoglobin is 50% saturated with oxygen)
values, although in a separate study they did suggest that the
increased umbilical plasma erythropoietin found in the neonates
of their diabetic patients might be mediated by fetal hypoxia. 13
The presence of fetal hypoxia in human diabetic pregnancy
was suggested as early as 1954 by Berglund and Zetterstrom. I4
This suggestion was made on the basis of increased erythro-
poiesis and decreased oxygen saturation in the umbilical cord
blood of 3 infants born to diabetic mothers. However, the
presence of vascular disease was not excluded in these patients.
More recently, Philipps el al. IS have shown that infusion of
tolbutamide into pregnant ewes through a fetal venous catheter
increased fetal insulin release and fetal glucose consumption,
and produced mild hypoxaemia as measured by an increased
umbilical venous-arterial oxygen content difference. This is in
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agreement with the earlier work of Carson el al. 16 and Quissell
el alY in fetal lambs. They showed that sustained fetal hyper-
insulinism (plasma insulin level 316 ± 60 ~U/ml for ± 48
hours) was associated with a fall in arterial oxygen content I6.17
and with increased fetal oxygen consumption I7 in these animals.
We wished to investigate this possibility further, to determine
whether fetal hypoxaemia was present in diabetic pregnancy
and to ascertain whether it was related to the fetal hyper-
insulinism often found in infants born to diabetic mothers.
Patients and methods
There were 13 pregnant patients with gestational diabetes
(GD) and their neonates in the study. Diabetes was diagnosed
early in pregnancy on the basis of an abnormal glucose tolerance
test result I8 and a fasting blood glucose level < 5,8 mmol/l.
Patients with vascular complications were carefully excluded
and the mothers of the infants studied were considered to have
well-controlled diabetes according to established criteria, i.e.
fasting blood glucose value < 5,8 mmol/l, 2-hour postprandial
glucose level < 8,3 mmol/l, and normal levels of total glyco-
sylated haemoglobin (HbAlla+b+c)). They were treated with a
standard diabetic diet. 19
No placental dysfunction or pre-eclampsia was present, and
in 12 cases there was a normal, uncomplicated vaginal delivery
at term, while in 1 case the infant was delivered by elective
caesarean section at 39Yz weeks. This baby was subsequently
shown to be macrosomic. No oxygen or nitrous oxide was
administered during labour and intrapartum euglycaemia was
monitored by frequent estimation of blood glucose levels.
Twelve normal mothers and their neonates (all delivered by
normal, uncomplicated vaginal delivery) were examined as
controls. All patients (diabetics and controls) received an
intravenous infusion of 5% dextrose in water during labour at
an infusion rate of < 10 g/h. It has been shown that this has
no effect on cord blood insulin levels. 20 Apgar scores for all
infants were within the normal range and informed consent for
the study was obtained from each patient studied. The study
was carried out in accordance with the requirements of the
Ethical Committee of this hospital.
Maternal venous blood was collected on the day of delivery
and umbilical cord blood was collected at delivery,2I before the
babies had taken their first breath. No epidural or other
anaesthetic was administered to mothers who had a normal
vaginal delivery. There was no evidence of cord compression
during delivery and in each patient studied the second stage of
labour \vas not unduly prolonged.
Relative birth weight ratios (BWRs) were determined after
Dubowitz examination22 using birth weight charts appropriate
for the local population.2)
C-peptide levels in umbilical cord blood specimens taken at
delivery21 were determined after polyethylene glycol precipi-
tation24 using a commercial radio-immunoassay kit from Byk-
Mallinckrodt (Germany).
The percentage of oxygen saturation of cord blood was
measured on an Instrumentation Laboratory (IL) co-oximeter
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Discussion
The results presented are consistent with the proposal that
hyperinsulinism in the fetuses of the GD patients in this study
Oxygen
saturation (%)
43,3
40,3
BWR
1,49
1,48
TABLE 11. NEONATAL CORD BLOOD VALUES IN 2
MACROSOMIC BABIES
C peptide P02
(ng/ml) (kPa)
3,2 3,1
2,6 3,0
GO
GO
Patient
class
babies were born to mothers with GD. Their BWRs and cord
blood C-peptide, percentage oxygen saturation and P02 values
are shown in Table 11. One of these babies was delivered by
elective caesarean section and the other was delivered normally
at 36 weeks.
The increase in C-peptide levels present in the neonates of
the GD patients was directly correlated with BWR (Fig. 1)
and inversely with oxygen saturation values (Fig. 2). The
oxygen saturation values in these neonates showed an inverse
correiation with BWR (Fig. 3). These correlations were not
present in neonates delivered to normal mothers.
Model 282 (Massachusens) and the panial pressure of oxygen
(P02) on an IL blood gas analyser Model 613. Both parameters
were measured in samples obtained anaerobically from umbili-
cal cord blood at delivery.
Plasma glucose levels were determined by a conventional
glucose oxidase method (Beckman Astra-8 Routine Analyser)
and total HbA 1 was measured on EDTA plasma using a
commercial kit (Diagnostic Corporation of America, Arlington,
Texas) utilizing an ion-exchange microcolumn chromatographic
procedure.
Comparison of means was carried out using the Mann-
Whitney U test and visual presentations were calculated using
linear regression analyses; significance was calculated by the
Spearman-Rank correlation test (two-tailed analyses).
Results
There was no significant difference in gestational age between
the two groups of neonates (Table I). Relative BWR and cord
blood C-peptide values were significantly higher in neonates
born to the mothers with GD (Table I). The percentage
oxygen saturation and P02 were lower (although this was not
significant) in neonates born to the mothers with GD (Table
I). There was no difference in cord blood pH in the two
groups, and if a birth weight above the 90th percentile for
gestational age is taken to indicate fetal macrosomia,3 then 2 of
the babies examined were macrosomic, and both of these
Gestational age (wks)
Maternal HbA, (0/0)
Cord glucose (mmolll)
Cord pH
BWR
Cord C peptide (ng/ml)
Cord oxygen saturation (0/0)
Cord P02 (kPa)
TABLE I. MEASUREMENTS IN THE NEONATES AND MATERNAL HbA, VALUES (MEAN ± SO)
Non-diabetic GO
(N=12) (N=13)
39,25 ± 1,16 (12) 38,92 ± 1,18 (13)
6,8 ± 0,7 (12) 7,0 ± 0,6 (13)
6,5 ± 2,4 (12) 5,9 ± 2,5 (13)
7,29 ± 0,08 (9) 7,28 ± 0,10 (10)
1,04 ± 0,10 (12) 1,16 ± 0,16* (12)
1,31 ± 0,53 (12) 2,16 ± 1,06* (13)
65,58 ± 11,91 (9) 55,43 ± 1,53 (10)
4,33 ± 0,76 (9) 3,94 ± 1,01 (10)
Figures in brackets refer to the number of patients examined. One patient did undergo a Dubowitz examination, and machine
breakdown reduced the number of blood gas determinations.
'p< 0,05.
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Fig. 1. BWR v. cord blood C-peptide values.
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may lead to the development of relative fetal hypoxaemia. In
this respect they agree with the work of Carson er al., 16
Quissell er al. 17 and Philipps er al. 15 in fetal lambs, and with
that of Widness er a/. 13 in subjects with GD and rhesus
monkeys.
It is difficult to be certain how closely the values in neonatal
cord blood reflect fetal values in urero during the third trimester.
Various techniques have been used to assess fetal function in
utero (e.g. examination of autopsy material25.26 and multiple
catheterization 15-17). Serial sampling from amniotic fluid and
serial ultrasonography were used in an elegant clinical study
by Ogara er al.,5 although neither of these latter techniques
would be useful in monitoring oxygenation of the fetus.
Sampling from cord blood at term has been used previously to
assess fetal pancreatic function/· 4. ll and the results which we
obtained using this procedure, while subject to the exigencies
of labour and not ideal as a measure of in utero fetal experience,
gave results which were consistent with those obtained by
other workers using other sampling procedures and (in some
cases) experimental animals. We feel that the mild fetal
hypoxaemia detected cannot be attributed to complications
during delivery or to placental abnormalities, since these
patients were excluded from this study. The conditions of
labour and gestational age at term (Table I) were similar in the
two groups studied, and we do riot believe that these factors
influenced our results.
Euglycaemia was maintained during labour and there was
no difference in cord blood glucose levels in the two groups of
infants (Table I). In addition, the patients with GD studied
were considered to be well controlled, and HbA I values were
within the normal range (Table I). Increased amounts of
minor maternal haemoglobin components therefore did not
contribute to the neonatal hypoxaemia which we found in
these infants. In spite of the good control of diabetes in the
mothers with GD, cord blood levels of C peptide (Table I)
were raised, and their neonates also showed a significant
increase in BWR (Table I) in comparison with neonates
delivered to normal mothers. The mild neonatal hypoxaemia
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which we found may be a consequence of this increase in fetal
weight, and we feel that the process was in progress before
birth, i.e. present in utero. The increase in BWR and C
peptide in the neonates of the mothers with G D and the
correlation of BWR with cord blood C-peptide values (Fig. 1)
suggest that fetal hyperinsulinism results in heavier babies
being born to the mothers with GD. This agrees with previously
published results. I- 5 In addition, the BWR (Fig. 3) of and the
C-peptide values (Fig. 2) in the neonates of the mothers with
GD were inversely correlated with percentage oxygen satura-
tion. These correlations were absent in neonates delivered to
normal mothers. This suggests that the mild hypoxaemia
found in the neonates born to mothers with G D may be
secondary to an insulin-induced increase in fetal weight.
Although the percentage oxygen saturation and P02 were
not significantly lower in the infants of the mothers with GD
(Table I), only 2 of these babies were macrosomic. The
correlations in Figs 1, 2 and 3 suggest that with poor control
of diabetes (all our patients were considered well controlled),
larger babies and significantly lower percentage oxygen satura-
tion and P02 values would develop. In the 2 macrosomic
babies examined, in spite of apparently good diabetic control,
C-peptide values were higher and this fetal hyperinsulinaemia
was associated with lower percentage oxygen saturation and
P02 values than were present in the other infants examined
(Table 11). One of these babies was delivered by caesarean
section while the other had a normal vaginal delivery.
Widness et al. 13 could find no difference in umbilical P02
values between neonates of normal mothers and those with
GD (caesarean section), and they could find no correlation
between umbilical arterial P02 and cord blood erythropoietin
in the neonates born to the mothers with GD. They did,
however, correlate LlP02 (Puvo2 - Pua02) values with erythro-
poietin levels in these laner neonates. The neonates born to
the mothers with GD in their study had significantly higher
birth weights and umbilical plasma insulin and erythropoietin
levels than infants born to normal mothers. These results
agree with our findings.
The percentage oxygen saturation is proportional to the
oxygen content of the blood, and although neither the oxygen
content of the cord blood nor the fetal oxygen consumption
was measured, we feel that the percentage oxygen saturation is
a useful index of hypoxaemia. It has been used previousli 1.14
together with measurements of fetal erythropoiesis '4 for this
purpose. In addition, cord blood fetal haemoglobin and 2,3-
diphosphoglyceric acid levels were significantly increased (un-
published observations) in the neonates born to the mothers
with GD. This, together with the lower percentage oxygen
saturation and P02 values found (Table I), is consistent with
the presence of hypoxic stress in these neonates.
We believe that our results are consistent with an insulin
effect on fetal oxygenation, albeit secondary to an increase in
fetal weight, in the fetuses of mothers with GD in the absence
of vascular disease. They indicate the presence of mild fetal
hypoxaemia in utero during the third trimester of pregnancy in
women with GD. This agrees with the work of Berglund and
Zetterstrom,14 and like them we suggest that interruption of
difficult diabetic pregnancies after 35-36 weeks of gestation
but before term seems advisable.
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